The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 16, 2022

Primary Completion Date

September 16, 2022

Study Completion Date

September 16, 2022

Conditions
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Interventions
OTHER

MedicijnWijs

"The mobile phone app MedicijnWijs will guide the participants with their azathioprine therapy during 6 weeks. Information about azathioprine is given as well as general information about IBD, specified to disease modality (Crohn's Disease and Ulcerative Colitis). Contact details of the patient's pharmacy are listed, questions about the patient's symptoms are asked, and push notifications are added to remind the patients to take their medication.~At the beginning of the 6-weeks guidance, two validated questionnaires that are translated and validated in Dutch will have to be filled in: the MARS-5 and the IBD-KID2. After 6 weeks, the participants have to fill out the same questionnaires again to assess potential changes in the scores compared to baseline. Also, a number of questions will be asked to assess the ease of use of MedicijnWijs."

Trial Locations (3)

5623EJ

NOT_YET_RECRUITING

Catharina Hospital, Eindhoven

6419PC

NOT_YET_RECRUITING

Zuyderland Medisch Centrum, Heerlen

5500VB

RECRUITING

Maxima Medical Center, Veldhoven

Sponsors
All Listed Sponsors
lead

Maxima Medical Center

OTHER